Immune response and long-term clinical outcome in advanced melanoma patients vaccinated with tumor-mRNA-transfected dendritic cells
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2016-10-18 / Oncoimmunology 2016;5(11):e1232237Immunotherapy in pancreatic cancer treatment: a new frontier
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2016-10-17 / Therap Adv Gastroenterol 2017 Jan;10(1):168-194Advances in immunotherapy for the treatment of glioblastoma
/in Glioblastoma, International Publications /von 2016-10-14 / J. Neurooncol. 2017 01;131(1):1-9Kongress der Deutschen Gesellschaft für Hyperthermie: Kurzinformation
/in Externe Meldungen /von IOZKMesenchymal stem cells enhance the oncolytic effect of Newcastle disease virus in glioma cells and glioma stem cells via the secretion of TRAIL
/in Glioblastoma, International Publications, Newcastle Disease Virus /von 2016-10-10 / Stem Cell Res Ther 2016 10;7(1):149Radiofrequency hyperthermia promotes the therapeutic effects on chemotherapeutic-resistant breast cancer when combined with heat shock protein promoter-controlled HSV-TK gene therapy: Toward imaging-guided interventional gene therapy
/in Breast Cancer, Hyperthermia, International Publications /von 2016-10-04 / Oncotarget 2016 Oct;7(40):65042-65051
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution